Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine

References

• Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974; 129:304 - 9; http://dx.doi.org/10.1093/infdis/129.3.304; PMID: 4361245
   PubMed Web of Science ®Google Scholar
• Ji H, Li L, Liu Y, Ge H, Wang X, Hu J, Wu B, Fu J, Zhang Z, Chen X, et al. Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China. Virol J 2012; 9:248; http://dx.doi.org/10.1186/1743-422X-9-248; PMID: 23102275
   PubMed Web of Science ®Google Scholar
• Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics 2007; 120:e244 - 52; http://dx.doi.org/10.1542/peds.2006-3331; PMID: 17671037
   PubMed Web of Science ®Google Scholar
• Akiyoshi K, Suga T, Mori A. Enteroviruses in patients experiencing multiple episodes of hand, foot, and mouth disease in the same season in Kobe, Japan, 2011. Jpn J Infect Dis 2012; 65:459 - 61; http://dx.doi.org/10.7883/yoken.65.459; PMID: 22996228
   PubMed Web of Science ®Google Scholar
• Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, Chow VT. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 2010; 14:e1076 - 81; http://dx.doi.org/10.1016/j.ijid.2010.07.006; PMID: 20952237
   PubMed Web of Science ®Google Scholar
• Tan X, Huang X, Zhu S, Chen H, Yu Q, Wang H, Huo X, Zhou J, Wu Y, Yan D, et al. The persistent circulation of enterovirus 71 in People’s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 2011; 6:e25662; http://dx.doi.org/10.1371/journal.pone.0025662; PMID: 21980521
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang H, Ding S, Wang X, Chen X, Wo Y, Wang L, Huang D, Liu W, Cao W. Prevalence of enteroviruses in children with and without hand, foot, and mouth disease in China. BMC Infect Dis 2013; 13:606; http://dx.doi.org/10.1186/1471-2334-13-606; PMID: 24370001
   PubMed Web of Science ®Google Scholar
• Kuo RL, Shih SR. Strategies to develop antivirals against enterovirus 71. Virol J 2013; 10:28; http://dx.doi.org/10.1186/1743-422X-10-28; PMID: 23339605
   PubMed Web of Science ®Google Scholar
• Zhang D, Lu J, Lu J. Enterovirus 71 vaccine: close but still far. Int J Infect Dis 2010; 14:e739 - 43; http://dx.doi.org/10.1016/j.ijid.2009.12.002; PMID: 20400350
   PubMed Web of Science ®Google Scholar
• Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 1995; 39:195 - 205; http://dx.doi.org/10.1016/0168-1702(95)00087-9; PMID: 8837884
   PubMed Web of Science ®Google Scholar
• McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26:91 - 107; http://dx.doi.org/10.1111/j.1574-6976.2002.tb00601.x; PMID: 12007645
   PubMed Web of Science ®Google Scholar
• Tung WS, Bakar SA, Sekawi Z, Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther 2007; 5:6; http://dx.doi.org/10.1186/1479-0556-5-6; PMID: 17445254
   PubMedGoogle Scholar
• Lin YC, Wu CN, Shih SR, Ho MS. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine 2002; 20:2485 - 93; http://dx.doi.org/10.1016/S0264-410X(02)00182-2; PMID: 12057603
   PubMed Web of Science ®Google Scholar
• Liu JN, Wang W, Duo JY, Hao Y, Ma CM, Li WB, Lin SZ, Gao XZ, Liu XL, Xu YF, et al. Combined peptides of human enterovirus 71 protect against virus infection in mice. Vaccine 2010; 28:7444 - 51; http://dx.doi.org/10.1016/j.vaccine.2010.08.080; PMID: 20831911
   PubMed Web of Science ®Google Scholar
• Foo DG, Alonso S, Chow VT, Poh CL. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 2007; 9:1299 - 306; http://dx.doi.org/10.1016/j.micinf.2007.06.002; PMID: 17890123
   PubMed Web of Science ®Google Scholar
• Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008; 26:1855 - 62; http://dx.doi.org/10.1016/j.vaccine.2008.01.058; PMID: 18329759
   PubMed Web of Science ®Google Scholar
• Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, Su IJ. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 2000; 7:523 - 8; http://dx.doi.org/10.1007/BF02253368; PMID: 11060501
   PubMed Web of Science ®Google Scholar
• Yang C, Deng C, Wan J, Zhu L, Leng Q. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Virol J 2011; 8:306; http://dx.doi.org/10.1186/1743-422X-8-306; PMID: 21679417
   PubMed Web of Science ®Google Scholar
• Chang LY, Hsiung CA, Lu CY, Lin TY, Huang FY, Lai YH, Chiang YP, Chiang BL, Lee CY, Huang LM. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res 2006; 60:466 - 71; http://dx.doi.org/10.1203/01.pdr.0000238247.86041.19; PMID: 16940249
   PubMed Web of Science ®Google Scholar
• Juhela S, Hyöty H, Lönnrot M, Roivainen M, Simell O, Ilonen J. Enterovirus infections and enterovirus specific T-cell responses in infancy. J Med Virol 1998; 54:226 - 32; http://dx.doi.org/10.1002/(SICI)1096-9071(199803)54:3<226::AID-JMV14>3.0.CO;2-F; PMID: 9515773
   PubMed Web of Science ®Google Scholar
• Foo DG, Ang RX, Alonso S, Chow VT, Quak SH, Poh CL. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin Microbiol Infect 2008; 14:286 - 8; http://dx.doi.org/10.1111/j.1469-0691.2007.01904.x; PMID: 18076666
   PubMed Web of Science ®Google Scholar
• Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, et al. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 2008; 26:2882 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.03.041; PMID: 18450335
   PubMed Web of Science ®Google Scholar
• Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001; 20:895 - 904; http://dx.doi.org/10.1016/S0264-410X(01)00385-1; PMID: 11738755
   PubMed Web of Science ®Google Scholar
• Wang M, Jiang S, Wang Y. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Biochem Biophys Res Commun 2013; 430:387 - 93; http://dx.doi.org/10.1016/j.bbrc.2012.11.035; PMID: 23159634
   PubMed Web of Science ®Google Scholar
• Kiener TK, Jia Q, Lim XF, He F, Meng T, Chow VT, Kwang J. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J 2012; 9:55; http://dx.doi.org/10.1186/1743-422X-9-55; PMID: 22361222
   PubMed Web of Science ®Google Scholar
• Zhao M, Bai Y, Liu W, Xiao X, Huang Y, Cen S, Chan PK, Sun X, Sheng W, Zeng Y. Immunization of N terminus of enterovirus 71 VP4 elicits cross-protective antibody responses. BMC Microbiol 2013; 13:287; http://dx.doi.org/10.1186/1471-2180-13-287; PMID: 24320792
   PubMed Web of Science ®Google Scholar
• Han X, Ying X, Huang H, Zhou S, Huang Q. Expression and purification of enterovirus type 71 polyprotein P1 using Pichia pastoris system. Virol Sin 2012; 27:254 - 8; http://dx.doi.org/10.1007/s12250-012-3256-7; PMID: 22899434
   PubMedGoogle Scholar
• AbuBakar S, Sam IC, Yusof J, Lim MK, Misbah S, MatRahim N, Hooi PS. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis 2009; 15:79 - 82; http://dx.doi.org/10.3201/eid1501.080264; PMID: 19116058
   PubMed Web of Science ®Google Scholar
• Lin TY, Chang LY, Hsia SH, Huang YC, Chiu CH, Hsueh C, Shih SR, Liu CC, Wu MH. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 2002; 34:Suppl 2 S52 - 7; http://dx.doi.org/10.1086/338819; PMID: 11938497
   PubMedGoogle Scholar
• Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 2003; 9:78 - 85; http://dx.doi.org/10.3201/eid1301.020112; PMID: 12533285
   PubMed Web of Science ®Google Scholar
• Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis 2009; 13:307 - 18; http://dx.doi.org/10.1016/j.ijid.2008.09.005; PMID: 19010076
   PubMed Web of Science ®Google Scholar
• Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, et al. Enterovirus 71 outbreak in the People’s Republic of China in 2008. J Clin Microbiol 2009; 47:2351 - 2; http://dx.doi.org/10.1128/JCM.00563-09; PMID: 19439545
   PubMed Web of Science ®Google Scholar
• Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis 2014; 14:308 - 18; http://dx.doi.org/10.1016/S1473-3099(13)70342-6; PMID: 24485991
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol 2009; 44:262 - 7; http://dx.doi.org/10.1016/j.jcv.2009.02.002; PMID: 19269888
   PubMed Web of Science ®Google Scholar
• Wu TC, Wang YF, Lee YP, Wang JR, Liu CC, Wang SM, Lei HY, Su IJ, Yu CK. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol 2007; 81:10310 - 5; http://dx.doi.org/10.1128/JVI.00372-07; PMID: 17626076
   PubMed Web of Science ®Google Scholar
• Chen HF, Chang MH, Chiang BL, Jeng ST. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 2006; 24:2944 - 51; http://dx.doi.org/10.1016/j.vaccine.2005.12.047; PMID: 16448730
   PubMed Web of Science ®Google Scholar
• Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007; 25:21 - 50; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141702; PMID: 17029568
   PubMed Web of Science ®Google Scholar
• Sadeharju K, Knip M, Virtanen SM, Savilahti E, Tauriainen S, Koskela P, Akerblom HK, Hyöty H, Finnish TRIGR Study Group. Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 2007; 119:941 - 6; http://dx.doi.org/10.1542/peds.2006-0780; PMID: 17473095
   PubMed Web of Science ®Google Scholar
• Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science 2001; 291:2370 - 6; http://dx.doi.org/10.1126/science.291.5512.2370; PMID: 11269318
   PubMed Web of Science ®Google Scholar
• Chakrabarti BK, Kong WP, Wu BY, Yang ZY, Friborg J, Ling X, King SR, Montefiori DC, Nabel GJ. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol 2002; 76:5357 - 68; http://dx.doi.org/10.1128/JVI.76.11.5357-5368.2002; PMID: 11991964
   PubMed Web of Science ®Google Scholar
• Fournillier A, Wychowski C, Boucreux D, Baumert TF, Meunier JC, Jacobs D, Muguet S, Depla E, Inchauspé G. Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites. J Virol 2001; 75:12088 - 97; http://dx.doi.org/10.1128/JVI.75.24.12088-12097.2001; PMID: 11711599
   PubMed Web of Science ®Google Scholar
• Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, et al. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine 2013; 31:2471 - 6; http://dx.doi.org/10.1016/j.vaccine.2013.03.015; PMID: 23541623
   PubMed Web of Science ®Google Scholar
• Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, Yao X, Gao F, Wu X, Xu M, Wang JZ. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother 2013; 9:1701 - 5; http://dx.doi.org/10.4161/hv.24949; PMID: 23744508
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang Y, Wang J, Zhao H, Jiang L, Che Y, Shi H, Li R, Mo Z, Huang T, et al. Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS One 2013; 8:e54451; http://dx.doi.org/10.1371/journal.pone.0054451; PMID: 23372725
   PubMed Web of Science ®Google Scholar
• Li YP, Liang ZL, Gao Q, Huang LR, Mao QY, Wen SQ, Liu Y, Yin WD, Li RC, Wang JZ. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine 2012; 30:3295 - 303; http://dx.doi.org/10.1016/j.vaccine.2012.03.010; PMID: 22426327
   PubMed Web of Science ®Google Scholar
• Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother 2012; 8:668 - 74; http://dx.doi.org/10.4161/hv.19521; PMID: 22634437
   PubMed Web of Science ®Google Scholar
• A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children. Mar 10, 2013 2013. http://www.deepdyve.com/lp/clinical-trials/a-protected-studyof-inactivated-ev71-vaccine-human-diploid-cellkmb-679kOYq0nc/1.
   Google Scholar
• Positive topline results from Phase III trial of Enterovirus 71 vaccine (Sinovac Biotech) against Hand, Foot and Mouth Disease. 2013. http://www.epgonline.org/news /2013/Mar/Positive-toplineresults-fromPhase.cfm.
   Google Scholar
• Li JX, Meng FY, Liang ZL, Mao QY, Zhu FC. How to understand the efficacy measurements for enterovirus type 71 vaccine?. [Epub ahead of print] Hum Vaccin Immunother 2013; 10; PMID: 24280898
   PubMed Web of Science ®Google Scholar
• Ciarkowska A, Jakubowska A. [Pichia pastoris as an expression system for recombinant protein production]. Postepy Biochem 2013; 59:315 - 21; PMID: 24364214
   PubMedGoogle Scholar
• Vogl T, Hartner FS, Glieder A. New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris. Curr Opin Biotechnol 2013; 24:1094 - 101; http://dx.doi.org/10.1016/j.copbio.2013.02.024; PMID: 23522654
   PubMed Web of Science ®Google Scholar